Non-coding RNAs as emerging molecular targets of gallbladder cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Gallbladder cancer, a common biliary tract malignancy, presents aggressive pathophysiology and a global health challenge.
• Late diagnosis often precludes curative resection, highlighting the need for novel diagnostic and therapeutic strategies.
• The identification of specific molecular targets for early detection, prognosis, and treatment remains a critical unmet need.

Purpose of the Study:

• To provide an updated overview of non-coding RNAs in gallbladder cancer.
• To explore the biogenesis, mechanisms of action, and cellular functions of non-coding RNAs in tumorigenesis.
• To discuss the prognostic and therapeutic potential of non-coding RNAs as biomarkers.

Main Methods:

• Literature review and synthesis of recent research on non-coding RNAs in gallbladder cancer.
• Analysis of the roles of microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) in cancer development.
• Evaluation of the potential of non-coding RNAs as diagnostic and therapeutic targets.

Main Results:

• Non-coding RNAs, including miRNAs and lncRNAs, are increasingly implicated in the development and progression of gallbladder cancer.
• These molecules play significant roles in cellular functions relevant to gallbladder tumorigenesis.
• Emerging evidence suggests non-coding RNAs hold promise as prognostic and therapeutic biomarkers.

Conclusions:

• Non-coding RNAs represent a significant area of investigation for understanding gallbladder cancer.
• Their involvement in tumorigenesis underscores their potential as biomarkers for early diagnosis and improved patient outcomes.
• Further research into non-coding RNAs could lead to novel therapeutic strategies for gallbladder cancer.